CLASS III ONGOING Drug recall · Reported 5 Nov 2025 · FDA Enforcement Report
Espumil, Lipophilic foam base, 24G15-T02 recalled by Letco Medical
Letco Medical is recalling Espumil, Lipophilic foam base, 24G15-T02-115604, distributed in Alabama. The recall was initiated on 12 Sep 2025 and the FDA has classified it as Class III.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0138-2026
- FDA event ID
- 97660
- Recalling firm
- Letco Medical, Decatur, AL
- Classification
- Class III
- Status
- Ongoing
- Recall initiated
- 12 Sep 2025
- FDA classified
- 29 Oct 2025
- Reported
- 5 Nov 2025
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Other Reasons
Timeline
| 12 Sep 2025 | Recall initiated by company | |
| 29 Oct 2025 | Classified by FDA | +47 days |
| 5 Nov 2025 | Published in enforcement report | +7 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Labeling: Not Elsewhere Classified
Product as listed by the FDA
Espumil, Lipophilic foam base, 500 ml, 24G15-T02-115604
Where it was distributed
Product was distributed to: Letco Medical, LLC 1316 Commerce Drive Decatur, AL 35601 Product was further distributed to 44 compounding pharmacies and 2 distributors.
Questions about this recall
Why was it recalled?
Labeling: Not Elsewhere Classified
Which lots are affected?
Batch # 24G15-T02-115604, exp. 11/30/2026
Where was it sold?
Product was distributed to: Letco Medical, LLC 1316 Commerce Drive Decatur, AL 35601 Product was further distributed to 44 compounding pharmacies and 2 distributors.
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class III mean?
Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from Letco Medical
All 2| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Estriol USP Micronized a) 100 gm recalled by Letco Medical | Letco Medical | Potency & Assay | AL |